Zimmer Biomet reports $1.87 billion net sales in second-quarter report
Click Here to Manage Email Alerts
Zimmer Biomet Holdings Inc. reported increased net sales and diluted earnings per share during its second quarter in 2023, according to a company press release.
The company reported net sales of $1.87 billion, a 4.9% increase compared with the prior year period and a 6% increase on a constant currency basis. Net earnings for the second quarter were $209.6 million, or $382.8 million on an adjusted basis. Diluted earnings per share were $1, and adjusted diluted earnings per share were $1.82.
“Our performance and execution in [the second quarter] allowed us to deliver another strong quarter that was above our expectations, despite ongoing challenges in the macroenvironment,” Bryan Hanson, chair, president and CEO of Zimmer Biomet, said in the release. “We are raising our financial guidance for the rest of 2023 based on our confidence in our business performance, the strength of our innovation pipeline and the Zimmer Biomet team's ability to deliver for our key stakeholders.”